
"Quality, regulatory and pharmacovigilance software and services for life sciences"
Founded
2016
10 years
Employees
1001-5000
Annual Revenue
Not Disclosed
(2026)
Products
3
IQVIA supplies life sciences quality, regulatory and pharmacovigilance software. Its listed products are SmartSolve eQMS, SmartSolve RIM and the Vigilance Platform. eQMS manages quality processes; RIM manages registrations, submissions and authority interactions. The two SmartSolve applications share a platform and can connect quality changes to affected registrations. Current licence dependencies require confirmation.
IQVIA Inc. is publicly traded on NYSE under IQV. It formed through the 2016 merger of Quintiles and IMS Health. Its Safety & Pharmacovigilance arm markets the modular, multi-tenant Vigilance Platform alongside 3,000+ safety professionals in 100+ countries. The safety figures and customer cases below apply to that business, not to SmartSolve RIM.
The Vigilance Platform is sold both as a stand-alone software subscription and as the technology layer beneath IQVIA's pharmacovigilance business-process services. It follows a "platform of platforms" architecture, with customers licensing individual modules, Vigilance Intake, Vigilance Case, Vigilance Periodics, Vigilance Submissions, Vigilance Analytics, Vigilance Signal, Vigilance Detect, Vigilance Collect, and Vigilance Administration, and composing the footprint they need.
Named PV customers include Sanofi (Project ARTEMIS, 700,000 adverse-reaction reports annually, full-platform replacement), Genentech/Roche (Vigilance Detect via ATHENA), Biovac (South Africa vaccine manufacturer), and at least one unnamed top-10 pharma processing 120,000+ AE cases per year via Vigilance Collect. The platform and IQVIA's PV services bench (3,000+ safety professionals globally) are tightly coupled, a lock-in concern for some buyers.
IQVIA Safety & PV is pharma-specialized, serving biopharma, vaccine, and MedTech safety teams. Customer base spans top-10 global pharma (Sanofi, Genentech/Roche, unnamed top-10 processing 120,000+ AE cases/year through Vigilance Collect) and emerging mid-cap (Biovac vaccine manufacturer). Vendor cites 3,000+ safety professionals supporting customers in 100+ countries. Total Vigilance Platform tenant count is not publicly disclosed. Vigilance Detect processes >4M records annually at Genentech ATHENA and 130,000+ audio files at 99% transcription accuracy in one engagement (vendor-reported). IQVIA frames the platform as a vehicle for buyers committed to AI-led "touchless" case processing.
Industries Served
IQVIA Inc. is publicly traded on NYSE under IQV, with multi-billion USD annual revenue. Vigilance Platform pricing is not publicly disclosed and described by the vendor as "a pricing model that offers cost certainty and rewards efficiency." Sanofi reports ~15% savings achieved vs prior state with a 50% target by 2027, suggesting a model that scales with case volume and rewards automation. IQVIA's data-migration SME role descriptions reference statements of work "for approximately $10M in annual revenue," indicating large-pharma engagement scale combining platform and services. No M&A specific to the Vigilance Platform is disclosed.
Browse all software products offered by IQVIA.
SaaS eQMS on Microsoft Azure for life sciences quality teams. Covers documents, CAPA, changes, audits, training and supplier quality, with connections to SmartSolve RIM and separately offered validation services.
Cloud regulatory information management software for pharmaceutical, MedTech and IVD teams. Covers submission publishing, product registrations, regulatory documents and health-authority correspondence, with links to SmartSolve quality processes.
A modular, multi-tenant SaaS pharmacovigilance platform that handles end-to-end safety case lifecycle (intake → case processing → submission → signal detection → periodic reporting) for biopharma, vaccine, and medical-device safety teams. IQVIA pairs the software with a global services bench (3,000+ safety professionals in 100+ countries) and embedded AI/NLP automation in the Vigilance Detect and Vigilance Intake modules.
SmartSolve eQMS covers documents, CAPA, changes, audits, training and supplier quality. SmartSolve RIM covers regulatory submissions, publishing, registrations, content and health-authority interactions. These are peer applications on a shared platform. Current licence and module dependencies require confirmation.
Vigilance Platform module family: Vigilance Intake (AI/NLP-driven case-creation automation), Vigilance Case (case-processing core with MedDRA/WHODrug coding and algorithmic duplicate identification), Vigilance Periodics (PSUR/PBRER, DSUR aggregate reporting), Vigilance Submissions (expedited and periodic submissions to global regulators), Vigilance Analytics (operational dashboards), Vigilance Signal (real-time signal detection and management), Vigilance Detect (NLP/GenAI AE detection across email, audio, chat, social, CRM in 50+ languages; sold both as part of the platform and as a stand-alone overlay onto third-party safety systems), Vigilance Collect (web + mobile reporter portal storing submissions in E2B+ format), and Vigilance Administration (lifecycle configuration, PLS, user security).
AI/ML on the platform: NLP-driven AE detection in 50+ languages, audio transcription with AE identification (Vigilance Detect), automated case validation/duplicate detection/redaction (Vigilance Intake), algorithmic follow-up identification (Vigilance Case), real-time signal-detection visualizations (Vigilance Signal). Roadmap: AI-driven targeted medical reviews; dynamic regulator-adaptive workflows; full medical evaluation automation by 2027 (Sanofi target); agentic AI / NVIDIA partnership (announced June 2025); application to the Vigilance Platform specifically is not yet GA.
Hosted on cloud infrastructure with a referenced 2023 IQVIA–Alibaba Cloud collaboration for China hosting (Everest Group). Underlying global cloud provider not publicly disclosed at Vigilance Platform granularity. Integration ecosystem references "system-agnostic" overlay capability for Vigilance Detect over third-party safety databases. Industry affiliations: ICH (E2B(R2)/E2B(R3)), EudraVigilance, MedDRA, WHODrug. Partnership with NVIDIA announced June 2025 for cross-IQVIA workflow agentic AI; application to Vigilance Platform not yet GA. IQVIA Safety & PV also operates as a managed-service partner to sponsors using competitor safety databases (Oracle Argus migration tooling referenced in job postings).
Technology Partners
Implementation, validation support, data migration, and managed PV services are priced as professional services and frequently combine with the platform license. IQVIA references 24×7 system support and a 3,000+ safety-professional services bench in 100+ countries. Migration methodology is named for Oracle Argus → Vigilance Platform; bidirectional migration practice exists (templates work both into and out of Argus). Statements of work referenced in job descriptions sit in the $10M+ annual range for data-migration SME work, indicating large engagement scale.
Analyst recognition: IQVIA named a Leader in IDC MarketScape Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment (doc # US48061622, December 2022). IDC explicitly cites the Vigilance Platform as the differentiator. IQVIA also named a Leader in Everest Group Pharmacovigilance and Complaint Management PEAK Matrix 2021 (services), Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix 2024 (adjacent, not PV platform-specific), and is assessed among 29 providers in the Everest Group Pharmacovigilance Operations PEAK Matrix 2025 (services). No Gartner Magic Quadrant or Forrester Wave covering PV software exists.
Certifications at the Vigilance Platform product level, including SOC 2 Type II, ISO 27001, HIPAA BAA, and Annex 11, are undisclosed on public product pages and available to buyers only under non-disclosure agreement.
IQVIA maintains an active press cadence on Vigilance Platform customer wins (Sanofi ARTEMIS multi-year coverage, Biovac case study) and Vigilance Detect AI metrics (50+ languages, 80% false-positive reduction, 99% audio transcription accuracy). Comprehensive documentation portal across iqvia.com Safety & PV. Independent review-platform coverage of the Vigilance Platform is thin: no dedicated, populated G2, Capterra, or Gartner Peer Insights product page as of 2026-05-14. The platform is heavily case-study-driven rather than logo-driven on the public site.
Market positioning: Vigilance Platform is framed as a true SaaS modern alternative to legacy on-prem safety databases ("no costly disruptive upgrades"), differentiated by AI/NLP across unstructured sources and by deep coupling with IQVIA's global PV services bench.
Headquarters
Durham, North Carolina, United States
Founded
2016 (10 years in business)
Company Size
1001-5000 employees
Type
Public
Owned by Not applicable - independent public company
Annual Revenue
Not Disclosed (2026)
Stock Ticker
$NYSE: IQVGlobal Reach
100 countries